Clinical implications of the global multidrug-resistant tuberculosis epidemic

Kartik Kumar, Ibrahim Abubakar*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)


Multidrug-resistant tuberculosis (MDR TB) is a significant threat to global health estimated to account for nearly half a million new cases and over 200,000 deaths in 2013. The number of MDR TB cases in the UK has risen over the last 15 years, with ever more complex clinical cases and associated challenging public health and societal implications. In this review, we provide an overview of the epidemiology of MDR TB globally and in the UK, outline the clinical management of MDR TB and summarise recent advances in diagnostics and prospects for new treatment.

Original languageEnglish
Pages (from-to)s37-s42
JournalClinical Medicine, Journal of the Royal College of Physicians of London
Publication statusPublished - 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Royal College of Physicians 2015. All rights reserved.


  • Diagnostics
  • Epidemiology
  • Multidrug-resistant tuberculosis
  • Treatment


Dive into the research topics of 'Clinical implications of the global multidrug-resistant tuberculosis epidemic'. Together they form a unique fingerprint.

Cite this